Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £608,000,000 |
| Release Date: | 3 April 2024 |
| Application Deadline: | 1 December 2023 |
| Contract Start Date: | 31 March 2024 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to (6 suppliers)
| Award value: | £608,000,000 |
| Award decision date: | 11 March 2024 |
| Award status: | Active |
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
1 December 2023
Closed
Estimated Value
£608,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 31 March 2028 |
| Contract Duration: | 4.1 years |
| Procurement ID (OCID): | ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c |
| Notice Reference: | 5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287 |